Preimplantation Genetic Testing Market Size, Share, and Growth Analysis, By Test Type, By Technology, By Category, By End-User, By Region - Industry Forecast 2026-2033

Global Preimplantation Genetic Testing Market size was valued at USD 943.31 Million in 2024 and is poised to grow from USD 1014.06 Million in 2025 to USD 1808.56 Million by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global market for preimplantation genetic testing is experiencing significant growth driven by an increase in genetic disorders and infertility rates, coupled with advancements in genetic screening technology and enhanced IVF infrastructure. The prevalence of genetic and chromosomal abnormalities, alongside rising infertility stemming from sedentary habits and environmental factors, fuels the demand for IVF and associated testing. Preimplantation genetic testing is vital in minimizing IVF cycle numbers while boosting success rates. Growing public awareness about genetic conditions, miscarriage risks, and maternal health, along with government initiatives supporting reproductive health, further bolster market expansion. However, challenges like high procedure costs, ethical dilemmas, a shortage of skilled professionals, and uncertainties surrounding clinical outcomes may hinder market penetration moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preimplantation Genetic Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preimplantation Genetic Testing Market Segments Analysis

Global Preimplantation Genetic Testing Market is segmented by Test Type, Technology, Category, End-User and region. Based on Test Type, the market is segmented into Preimplantation Genetic Diagnosis (PGD), Preimplantation Genetic Screening (PGS) / Aneuploidy Screening, HLA Typing / Embryo Matching and Others. Based on Technology, the market is segmented into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Comparative Genomic Hybridization / Microarray and Single-Nucleotide Polymorphism (SNP) & AI-based Platforms. Based on Category, the market is segmented into Reagents & Consumables, Instruments / Platforms and Software & Bioinformatics Services. Based on End-User, the market is segmented into Fertility Clinics / IVF Centres, Hospitals & Assisted Reproductive Technology (ART) Centres and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Preimplantation Genetic Testing Market

The global preimplantation genetic testing market is being significantly driven by the growing number of IVF centers, fertility clinics, and specialized diagnostic laboratories worldwide, which are enhancing the demand for these services. Additionally, substantial investments in reproductive healthcare infrastructure, particularly in emerging economies, are generating fresh opportunities for providers of preimplantation genetic testing. This expansion of fertility service infrastructure on a global scale is playing a crucial role in shaping the positive outlook for the market, as it accommodates the increasing need for advanced reproductive technologies and genetic screening methods aimed at improving patient outcomes and ensuring successful pregnancies.

Restraints in the Global Preimplantation Genetic Testing Market

The Global Preimplantation Genetic Testing market faces significant challenges due to the high costs associated with these advanced procedures, which significantly increase the overall expense of the in vitro fertilization (IVF) process. The substantial financial burden can deter couples with limited financial resources from pursuing this option. Factors contributing to the elevated costs include the sophisticated technology, necessary laboratory infrastructure, and specialized expertise required for these tests. Additionally, the absence of reimbursement options exacerbates the situation, rendering preimplantation genetic testing largely unattainable for individuals in lower- and middle-income regions, further limiting its adoption and accessibility.

Market Trends of the Global Preimplantation Genetic Testing Market

The Global Preimplantation Genetic Testing market is witnessing a significant shift toward non-invasive genetic testing approaches, propelled by an increasing preference for minimally invasive procedures. Innovations in the analysis of cell-free DNA from spent embryo culture media are gaining traction, allowing for comprehensive genetic testing without the need for direct embryo cell extraction. This advancement not only minimizes potential damage to embryos but also enhances safety and efficiency, positioning non-invasive techniques as a favorable option for prospective parents. As awareness of these benefits spreads, the demand for safer genetic testing methods is expected to shape the future landscape of the market.